GSK looks like it is starting to show the benefit of a revamp of its business under chief executive Emma Walmsley, with recent product launches driving a 10% rise in sales in the first quarter of ...

Volta Medical announces positive results from transatlantic TAILORED-AF trial on guided AI procedure During the week of 20th ...

Health technology assessment (HTA) agency NICE has worked with NHS England and other stakeholders, including the MHRA ...

Major pharma companies use an extensive array of legal manoeuvres to keep competition at bay for years, if not decades, after ...

AffyImmune’s CAR-T platform relies on a technology known as affinity tuning, which increases the specificity of the T cells ...

Among the myriad of new studies highlighted in the newly published ASCO abstracts, Merus’ seems to have struck a chord with ...

This week’s round-up of biotech financings is led by a $120 million round for UK-based antibody-drug conjugate (ADC) ...

In a statement, Cytokinetics said that part of the Royalty Pharma cash will go towards the commercial launch of cardiac myosin inhibitor aficamten, which is being prepared for filing in the US and ...

Regardless of fluctuations in funding, the geopolitical climate, and macroeconomic headwinds, companies in this space are ...

The latest blaze is thought to have started in a container at a neighbouring site where the pharma group is carrying out ...

The $1.8 billion deal – which comes just weeks after Biogen chief executive Chris Viehbacher said the company wasn’t ...

How can it be made to function in a clinical trial? They discuss some of the hurdles involved in getting the FDA to accept ...